Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Aug;88(4):569–576. doi: 10.1046/j.1365-2567.1996.d01-695.x

Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease.

A C Issekutz 1, L Ayer 1, M Miyasaka 1, T B Issekutz 1
PMCID: PMC1456635  PMID: 8881759

Abstract

The migration of leucocytes from blood into the joint is a key feature of human and experimental arthritis. Adhesion molecules on leucocytes and vascular endothelium are important in this process and may be therapeutic targets for intervention in arthritis. We investigated whether monoclonal antibody treatment to block the alpha 4 integrin, very late activation antigen-4 (VLA-4), and beta 2 integrins (CD11/CD18) administered to rats during the preclinical (day 5) or clinical phase (day 10+) would modify disease. When treatment was initiated 5 days after induction of disease, development of arthritis was significantly reduced by either anti-alpha 4 (TA-2) or anti-beta 2 (WT.3) monoclonal antibodies (mAb) and the combination of both mAb was even more effective (clinical scores: control 11.4; anti-alpha 4 6.6; anti-beta 2 6.8; anti-alpha 4 + anti-beta 2 3.9). When treatment was delayed until arthritis was apparent (day 10), the anti-alpha 4 + anti-beta 2 mAb combination still significantly diminished the arthritis score on day 14 (control 13; anti-alpha 4 + anti-beta 2 7.9). Treatment with anti-alpha 4 + anti-beta 2 mAb decreased the migration to the joints of blood polymorphonuclear leucocytes (PMNL) by 66-79% and of spleen T lymphocytes by 56-75%, depending on the joint. In contrast, PMNL migration was abolished (> 98%) and T-cell migration markedly (87%) inhibited to dermal inflammatory reactions in the same animals. These findings demonstrate: that blocking mAb to alpha 4 and beta 2 integrins can reduce the severity of adjuvant arthritis, even after joint inflammation has developed; that this treatment can markedly inhibit PMNL and T-lymphocyte migration to the joints; and that yet to be defined mechanisms distinct from alpha 4 (CD49d) and beta 2 (CD11/CD18) integrins, also contribute to leucocyte migration to inflamed joints. Identifying these additional adhesion mechanisms may be required to control joint inflammation further.

Full text

PDF
569

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbadillo C., G-Arroyo A., Salas C., Mulero J., Sánchez-Madrid F., Andreu J. L. Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis. Springer Semin Immunopathol. 1995;16(4):427–436. doi: 10.1007/BF00196098. [DOI] [PubMed] [Google Scholar]
  2. Bevilacqua M. P. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767–804. doi: 10.1146/annurev.iy.11.040193.004003. [DOI] [PubMed] [Google Scholar]
  3. Brennan F. M., Maini R. N., Feldmann M. TNF alpha--a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992 May;31(5):293–298. doi: 10.1093/rheumatology/31.5.293. [DOI] [PubMed] [Google Scholar]
  4. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  5. Chuluyan H. E., Issekutz A. C. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes. J Clin Invest. 1993 Dec;92(6):2768–2777. doi: 10.1172/JCI116895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cush J. J., Rothlein R., Lindsley H. B., Mainolfi E. A., Lipsky P. E. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum. 1993 Aug;36(8):1098–1102. doi: 10.1002/art.1780360810. [DOI] [PubMed] [Google Scholar]
  7. Doerschuk C. M., Winn R. K., Coxson H. O., Harlan J. M. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol. 1990 Mar 15;144(6):2327–2333. [PubMed] [Google Scholar]
  8. Dustin M. L., Springer T. A. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol. 1991;9:27–66. doi: 10.1146/annurev.iy.09.040191.000331. [DOI] [PubMed] [Google Scholar]
  9. Ferrante A., Kowanko I. C., Bates E. J. Mechanisms of host tissue damage by cytokine-activated neutrophils. Immunol Ser. 1992;57:499–521. [PubMed] [Google Scholar]
  10. Foster S. J., Cunliffe C. J., McCormick M. E. Polymorphonuclear leukocytes induce damage to the articular cartilage in acute immunologic arthritis in rabbits. Biochem Pharmacol. 1988 Mar 15;37(6):1181–1183. doi: 10.1016/0006-2952(88)90531-x. [DOI] [PubMed] [Google Scholar]
  11. Furie M. B., Randolph G. J. Chemokines and tissue injury. Am J Pathol. 1995 Jun;146(6):1287–1301. [PMC free article] [PubMed] [Google Scholar]
  12. Gao J. X., Issekutz A. C., Issekutz T. B. Neutrophils migrate to delayed-type hypersensitivity reactions in joints, but not in skin. Mechanism is leukocyte function-associated antigen-1-/Mac-1-independent. J Immunol. 1994 Dec 15;153(12):5689–5697. [PubMed] [Google Scholar]
  13. Gao J. X., Wilkins J., Issekutz A. C. Migration of human polymorphonuclear leukocytes through a synovial fibroblast barrier is mediated by both beta 2 (CD11/CD18) integrins and the beta 1 (CD29) integrins VLA-5 and VLA-6. Cell Immunol. 1995 Jul;163(2):178–186. doi: 10.1006/cimm.1995.1114. [DOI] [PubMed] [Google Scholar]
  14. Halloran P. F., Madrenas J. The mechanism of action of cyclosporine: a perspective for the 90's. Clin Biochem. 1991 Feb;24(1):3–7. doi: 10.1016/0009-9120(91)90063-k. [DOI] [PubMed] [Google Scholar]
  15. Harris E. D., Jr Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990 May 3;322(18):1277–1289. doi: 10.1056/NEJM199005033221805. [DOI] [PubMed] [Google Scholar]
  16. Hawkins H. K., Heffelfinger S. C., Anderson D. C. Leukocyte adhesion deficiency: clinical and postmortem observations. Pediatr Pathol. 1992 Jan-Feb;12(1):119–130. doi: 10.3109/15513819209023288. [DOI] [PubMed] [Google Scholar]
  17. Hogg N., Clive Landis R., Bates P. A., Stanley P., Randi A. M. The sticking point: How integrins bind to their ligands. Trends Cell Biol. 1994 Nov;4(11):379–382. doi: 10.1016/0962-8924(94)90044-2. [DOI] [PubMed] [Google Scholar]
  18. Hogg N., Landis R. C. Adhesion molecules in cell interactions. Curr Opin Immunol. 1993 Jun;5(3):383–390. doi: 10.1016/0952-7915(93)90057-y. [DOI] [PubMed] [Google Scholar]
  19. Iigo Y., Takashi T., Tamatani T., Miyasaka M., Higashida T., Yagita H., Okumura K., Tsukada W. ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J Immunol. 1991 Dec 15;147(12):4167–4171. [PubMed] [Google Scholar]
  20. Issekutz A. C., Chuluyan H. E., Lopes N. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J Leukoc Biol. 1995 Apr;57(4):553–561. doi: 10.1002/jlb.57.4.553. [DOI] [PubMed] [Google Scholar]
  21. Issekutz A. C., Issekutz T. B. A major portion of polymorphonuclear leukocyte and T lymphocyte migration to arthritic joints in the rat is via LFA-1/MAC-1-independent mechanisms. Clin Immunol Immunopathol. 1993 Jun;67(3 Pt 1):257–263. doi: 10.1006/clin.1993.1073. [DOI] [PubMed] [Google Scholar]
  22. Issekutz A. C., Issekutz T. B. Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J Exp Med. 1995 Mar 1;181(3):1197–1203. doi: 10.1084/jem.181.3.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Issekutz A. C., Issekutz T. B. Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat. Lab Invest. 1991 May;64(5):656–663. [PubMed] [Google Scholar]
  24. Issekutz A. C., Issekutz T. B. The contribution of LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in vivo migration of polymorphonuclear leucocytes to inflammatory reactions in the rat. Immunology. 1992 Aug;76(4):655–661. [PMC free article] [PubMed] [Google Scholar]
  25. Issekutz A. C., Meager A., Otterness I., Issekutz T. B. The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin Exp Immunol. 1994 Jul;97(1):26–32. doi: 10.1111/j.1365-2249.1994.tb06574.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Issekutz A. C., Movat K. W., Movat H. Z. Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5ades arg: probable role of polymorphonuclear leucocyte lysosomes. Clin Exp Immunol. 1980 Sep;41(3):512–520. [PMC free article] [PubMed] [Google Scholar]
  27. Issekutz T. B. In vivo blood monocyte migration to acute inflammatory reactions, IL-1 alpha, TNF-alpha, IFN-gamma, and C5a utilizes LFA-1, Mac-1, and VLA-4. The relative importance of each integrin. J Immunol. 1995 Jun 15;154(12):6533–6540. [PubMed] [Google Scholar]
  28. Issekutz T. B. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo. J Immunol. 1991 Dec 15;147(12):4178–4184. [PubMed] [Google Scholar]
  29. Issekutz T. B., Issekutz A. C. T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4. Clin Immunol Immunopathol. 1991 Dec;61(3):436–447. doi: 10.1016/s0090-1229(05)80014-5. [DOI] [PubMed] [Google Scholar]
  30. Issekutz T. B., Wykretowicz A. Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat. J Immunol. 1991 Jul 1;147(1):109–116. [PubMed] [Google Scholar]
  31. Jasin H. E., Lightfoot E., Davis L. S., Rothlein R., Faanes R. B., Lipsky P. E. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum. 1992 May;35(5):541–549. doi: 10.1002/art.1780350508. [DOI] [PubMed] [Google Scholar]
  32. Johnson B. A., Haines G. K., Harlow L. A., Koch A. E. Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 1993 Feb;36(2):137–146. doi: 10.1002/art.1780360203. [DOI] [PubMed] [Google Scholar]
  33. Kavanaugh A. F., Davis L. S., Nichols L. A., Norris S. H., Rothlein R., Scharschmidt L. A., Lipsky P. E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 1994 Jul;37(7):992–999. doi: 10.1002/art.1780370703. [DOI] [PubMed] [Google Scholar]
  34. Lazarovits A. I., Karsh J. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol. 1993 Dec 1;151(11):6482–6489. [PubMed] [Google Scholar]
  35. Machold K. P., Kiener H. P., Graninger W., Graninger W. B. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol. 1993 Jul;68(1):74–78. doi: 10.1006/clin.1993.1098. [DOI] [PubMed] [Google Scholar]
  36. Mason J. C., Kapahi P., Haskard D. O. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 1993 Apr;36(4):519–527. doi: 10.1002/art.1780360412. [DOI] [PubMed] [Google Scholar]
  37. Meerschaert J., Furie M. B. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J Immunol. 1994 Feb 15;152(4):1915–1926. [PubMed] [Google Scholar]
  38. Mikecz K., Brennan F. R., Kim J. H., Glant T. T. The role of adhesion molecules in the development of autoimmune arthritis. Scand J Rheumatol Suppl. 1995;101:99–106. doi: 10.3109/03009749509100908. [DOI] [PubMed] [Google Scholar]
  39. Muller W. A., Weigl S. A., Deng X., Phillips D. M. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993 Aug 1;178(2):449–460. doi: 10.1084/jem.178.2.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Osborn L., Vassallo C., Browning B. G., Tizard R., Haskard D. O., Benjamin C. D., Dougas I., Kirchhausen T. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol. 1994 Feb;124(4):601–608. doi: 10.1083/jcb.124.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Postigo A. A., Garcia-Vicuña R., Diaz-Gonzalez F., Arroyo A. G., De Landázuri M. O., Chi-Rosso G., Lobb R. R., Laffon A., Sánchez-Madrid F. Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J Clin Invest. 1992 May;89(5):1445–1452. doi: 10.1172/JCI115734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28;76(2):301–314. doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  43. Szekanecz Z., Haines G. K., Lin T. R., Harlow L. A., Goerdt S., Rayan G., Koch A. E. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 1994 Feb;37(2):221–231. doi: 10.1002/art.1780370211. [DOI] [PubMed] [Google Scholar]
  44. Tamatani T., Kotani M., Miyasaka M. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur J Immunol. 1991 Mar;21(3):627–633. doi: 10.1002/eji.1830210314. [DOI] [PubMed] [Google Scholar]
  45. Taurog J. D., Argentieri D. C., McReynolds R. A. Adjuvant arthritis. Methods Enzymol. 1988;162:339–355. doi: 10.1016/0076-6879(88)62089-1. [DOI] [PubMed] [Google Scholar]
  46. Vonderheide R. H., Tedder T. F., Springer T. A., Staunton D. E. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol. 1994 Apr;125(1):215–222. doi: 10.1083/jcb.125.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wahl S. M., Allen J. B., Hines K. L., Imamichi T., Wahl A. M., Furcht L. T., McCarthy J. B. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest. 1994 Aug;94(2):655–662. doi: 10.1172/JCI117382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Williams J. H., Jr, Moser K. M., Ulich T., Cairo M. S. Harvesting the noncirculating pool of polymorphonuclear leukocytes in rats by hetastarch exchange transfusion (HET): yield and functional assessment. J Leukoc Biol. 1987 Nov;42(5):455–462. doi: 10.1002/jlb.42.5.455. [DOI] [PubMed] [Google Scholar]
  49. Winn R. K., Harlan J. M. CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits. J Clin Invest. 1993 Sep;92(3):1168–1173. doi: 10.1172/JCI116686. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES